Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer

Cancer Investigation

Volumn 32, Issue 8, 2014, Pages 394-401

  Zhu, Wang Yu ^b   Luo, Bin ^b   An, Ji Yuan ^c   He, Jian Ying ^b   Chen, Dong Dong ^b   Xu, Li Yun ^b   Huang, Yan Yan ^b   Liu, Xiao Guang ^b   Le, Han Bo ^a   Zhang, Yong Kui ^a  

^a Zhoushan Hospital   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c INSTITUTE OF PLANT PROTECTION AND MICROBIOLOGY   (China)

Author keywords

Early detection; MiRNA; NSCLC; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; MICRORNA; MICRORNA 125A 5P; MICRORNA 30A; MICRORNA 30E; MICRORNA 30E 3P; PROTEIN; PROTEIN LET 7E; UNCLASSIFIED DRUG; MIRN125 MICRORNA, HUMAN; MIRNLET7 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DEDIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PREDICTION; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; BIOSYNTHESIS; BLOOD; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL DEDIFFERENTIATION; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84907046260     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2014.922569     Document Type: Article

References (33)

1. Miller YE: Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 2005;33(3):216-223.
2. Ventura A, Jacks T.MicroRNAs and cancer: short RNAs go a long way. Cell 2009;136(4):586-591.
3. Schetter AJ, Heegaard NHH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010;31(1):37-49.
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL,Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005;435(7043):834-838.
5. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006;103(7):2257-2261.
6. Yu SL, ChenHY, Chang GC, Chen CY, ChenHW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, ChenWJ, Liu CC, ChanWK, ChenWJ, Li KC, Chen JJ, Yang PC.MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13(1):48-57.
7. Chen X, Ba Y,Ma L, Cai X, Yin Y,Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y,Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18(10):997-1006.
8. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H. serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small cell lung cancer. J Clin Oncol 2010;28(10):1721-1726.
9. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, LinDW, UrbanN,Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105(30):10513-10518.
10. Zhu W, Xu H, Zhu DX, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol 2012;69(3):723-731.
11. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, Calabr E, Croce CM, Pastorino U, Sozzi G. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011;108(9):3713-3718.
12. Heegaard NHH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating micro-RNA expression profiles in early stage non small cell lung cancer. Int J Cancer 2012;130(6):1378-1386.
13. Livak KJ, Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) method. Methods 2001;25(4):402-408.
14. Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ, Wang YK, Zeng F, Zhou JH, Zhang YK. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012;29(2):618-626.
15. MavrakisKJ, VanDer Meulen J, WolfeAL, LiuX,Mets E, Taghon T, Khan AA, Setty M, Rondou P, Vandenberghe P, Delabesse E, Benoit Y, Socci NB, Leslie CS, Van Vlierberghe P, Speleman F, Wendel HG. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet 2011;43(7):673-678.
16. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 2010;16(2):610-619.
17. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9(3):189-198.
18. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, Tucker MA, Bertazzi PA, Pesatori AC,CaporasoNE, McShane LM,Wang E.MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010;16(2):430-441.
19. Boyerinas B PS, Hau A, Murmann AE, Peter ME. The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 2010;17(1):F19-F36.
20. Buechner J, T mte E, Haug B, Henriksen J, L kke C, Fl gstad T, Einvik C. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma. Bri J Cancer 2011;105(2):296-303.
21. Osada H, Takahashi T. let-7 and miR-17-92: small-sized major players in lung cancer development. Cancer Sci 2011;102(1):9-17.
22. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120(1):15-20.
23. Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion andmigration of lung cancer cells.BMC Cancer 2010;10:318-331.
24. Wang G, Mao W, Zheng S, Ye J. Epidermal growth factor receptor-regulated miR-125a-5p-a metastatic inhibitor of lung cancer. FEBS J 2009;276(19):5571-5578.
25. Wu F, Zhu S, Ding Y, Beck WT, Mo YY. MicroRNA-mediated regulating of Ubc9 expression in cancer cells. Clin Cancer Res 2009;15(5):1550-1557.
26. Sugihara H, Ishimoto T, Watanabe M, Sawayama H, Iwatsuki M, Baba Y, Komohara Y, Takeya M, Baba H. Identification of miR-30e∗ regulation of Bmi 1 expression mediated by tumor-associated macrophages ingastrointestinal cancer. PLoS One 2013;8(11):e81839.
27. Zhao H, Ding Y, Tie B, Sun ZF, Jiang JY, Zhao J, Lin X, Cui S. miRNA expression pattern associated with prognosis in elderly patients with advanced OPSC and OCC. Int J Oncol 2013;43(3):839-849.
28. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 2011;6(3):482-488.
29. Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C, Wang C, Ren Z, Zhao Y, Wu S, Zhuang R, Zhang Y, Hu H, Liu C, Xu L, Wang J, Shen H, Zhang J, Zen K, Zhang CY. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel non-nvasive biomarkers for non-small cell lung cancer diagnosis. Int J Cancer 2012;130(7):1620-1628.
30. Keller A, Leidinger P,Gislefoss R,Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011;8(3):506-516.
31. Liu J, Mao Q, Liu Y, Hao X, Zhang S, Zhang J. Analysis of miR-205 andmiR-155 expression in the blood of breast cancer patients. Chin J Cancer Res 2013;25(1):46-54.
32. Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, Glover A, Sywak MS, Delbridge LW, Robinson BG, Sidhu SB. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer 2013;119(24):4358-4365.
33. Gao F, Wang H, Zhang G. Potential diagnostic value of miR-155 in serum from lung adenocarcinoma patients. Oncol Rep 2014;31(1):351-357.